Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-16 Sale |
2024-05-17 9:06 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,381 | $28.27 | $67,310 | 148,179 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:05 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
2,738 | $28.27 | $77,402 | 154,062 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:04 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,588 | $28.27 | $73,162 | 116,695 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:03 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,774 | $28.27 | $78,420 | 136,634 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-13 06:04 am |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
29,491 | $26.59 | $784,248 | 156,800 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-13 06:04 am |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
109,601 | $26.11 | $2,861,373 | 169,542 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 9:58 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
2,615 | $25.65 | $67,082 | 150,560 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 9:57 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
88,924 | $26.19 | $2,329,007 | 129,138 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-12 9:56 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
429,730 | $25.89 | $11,125,776 | 754,536 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 9:42 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,081 | $25.7 | $53,482 | 152,352 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:57 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
9,086 | $25.85 | $234,873 | 554,385 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:56 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
2,373 | $25.85 | $61,342 | 154,433 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:56 pm |
Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer |
1,591 | $25.85 | $41,127 | 186,291 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:52 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
9,921 | $25.86 | $256,585 | 153,175 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:50 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,434 | $25.85 | $62,919 | 141,184 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:45 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
2,273 | $25.85 | $58,757 | 121,955 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 5:08 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
46,534 | $30.05 | $1,398,347 | 6,545,479 (Indirect) |
View |
| 2024-03-01 Sale |
2024-03-05 5:07 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
46,534 | $30.05 | $1,398,347 | 2,306,079 (Indirect Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:38 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $28.96 | $2,895,519 | 1,052,995 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:37 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $28.46 | $811,865 | 167,878 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:37 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $28.05 | $357,296 | 133,539 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-28 7:15 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
807,838 | $24.3 | $19,626,903 | 864,487 (Indirect) |
View |
| 2024-02-26 Sale |
2024-02-28 7:13 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
807,838 | $24.3 | $19,626,903 | 6,562,578 (Indirect Direct) |
View |
| 2024-02-28 Sale |
2024-02-28 5:06 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
407 | $25 | $10,175 | 163,096 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 6:59 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
500,789 | $22.64 | $11,339,780 | 920,843 (Indirect) |
View |
| 2024-02-21 Sale |
2024-02-23 6:58 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner |
500,789 | $22.64 | $11,339,780 | 7,273,405 (Indirect Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 6:36 pm |
Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director |
510,152 | $23.26 | $11,867,292 | 9,359,331 (Indirect) |
View |
| 2024-02-15 Sale |
2024-02-20 6:35 pm |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner |
510,152 | $23.26 | $11,867,292 | 6,815,965 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-14 4:27 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
5,493 | $25.07 | $137,710 | 163,503 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-26 7:49 pm |
Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer |
100 | $25 | $2,500 | 168,996 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-26 7:48 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $24.53 | $490,510 | 172,146 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-26 7:47 pm |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $24.34 | $316,420 | 136,968 (Direct) |
View |
| 2024-01-09 Purchase |
2024-01-11 4:31 pm |
Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner |
1,714,285 | $17.5 | $29,999,988 | 1,428,571 (Indirect) |
View |
| 2024-01-03 Sale |
2024-01-04 9:49 pm |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
269,719 | $18.66 | $5,032,915 | 711,370 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 9:48 pm |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
87,779 | $18.57 | $1,629,985 | 240,332 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2024-04-04 9:07 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Cox John CEO & President |
0 | $0 | 5,000 (Direct) |
View |
| 2023-07-11 Option Award |
2024-04-04 9:06 pm |
N/A 2033-07-10 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 4:24 pm |
N/A 2034-03-24 |
Dyne Therapeutics Inc. | DYN | Cox John See Remarks |
679,853 | $0 | 679,853 (Direct) |
View |
Ownership |
2024-03-27 4:13 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Cox John See Remarks |
0 | $0 | 10,000 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $0 | 169,542 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $5.54 | 169,542 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:57 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
86,252 | $0 | 129,138 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:57 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
86,252 | $5.54 | 129,138 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:56 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
413,343 | $0 | 754,536 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 9:56 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
413,343 | $5.54 | 754,536 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:38 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $0 | 1,052,995 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:38 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
100,000 | $5.54 | 1,052,995 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0 | 167,878 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0.73 | 167,878 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $0 | 133,539 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
12,740 | $1.03 | 133,539 (Direct) |
View |
| 2024-01-29 Gift |
2024-01-31 4:18 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
21,500 | $0 | 563,471 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:48 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0 | 172,146 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:48 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0.73 | 172,146 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:47 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $0 | 136,968 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:47 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. |
13,000 | $1.03 | 136,968 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:49 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
269,719 | $0 | 711,370 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:49 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
69,719 | $1.03 | 711,370 (Direct) |
View |
| 2024-01-04 Exercise |
2024-01-04 9:49 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President |
200,000 | $5.54 | 711,370 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:48 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
68,000 | $0 | 240,332 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:48 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer |
68,000 | $1.03 | 240,332 (Direct) |
View |